Context Considerable advances have been made in the first-line treatment of metastatic
renal cell carcinoma (mRCC), with immunotherapy-based combinations including …

Importance Bone resorption inhibitors (BRIs) are recommended by international guidelines
to prevent skeletal-related events (SREs) among patients with metastatic castration-resistant …

Although chemoimmunotherapy improves outcomes for patients with follicular lymphoma (FL),
approximately 20% of patients experience early disease progression within two years of …

Background The PROSPECT trial (N1048) is evaluating the selective use of chemoradiation
in patients with cT2N1 and cT3N0-1 rectal cancer undergoing sphincter-sparing low …

Over the last number of years, the treatment of metastatic renal cell cancer has evolved
tremendously with the advent of targeted therapy. Previously, immunotherapies, such as …

Several systems (tumor‐node‐metastasis [ TNM ], Barcelona Clinic Liver Cancer [ BCLC ],
Okuda, Cancer of the Liver Italian Program [ CLIP ], and albumin–bilirubin grade [ ALBI ]) were …

Background: The impact of the change in the neutrophil-to-lymphocyte ratio (NLR) during
neoadjuvant chemotherapy (NAC) on outcomes in patients with muscle-invasive bladder …

Background The CELESTIAL, RESORCE, and REACH‐2 trials showed survival benefit of
cabozantinib, regorafenib, and ramucirumab, respectively, in hepatocellular carcinoma (HCC) …

Background Nearly half of patients with colorectal cancer develop liver metastases. Radical
resection of colorectal liver metastases (CRLM) offers the best chance of cure, significantly …

Background To describe patterns of referral, consultation, and treatment of advanced pancreatic
cancer patients in a population‐based health care system and to evaluate the impact of …